Aslıhan Pekmezci

6PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples biomedical and clinical sciencePredictive and prognostic markersMolecular evolutionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Hematological changes in Cushing's disease from diagnosis to remission: comparison with non-functioning pituitary adenomas.

|May 23, 2026
Patient-reported outcomes in a Pituitary Tumor Center of Excellence (PTCOE)-aligned pituitary clinic compared with general endocrinology care.

|May 13, 2026
Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022.

|Jul 24, 2025
Progeroid features in a patient with Malouf syndrome due to a rare LMNA variant: a case report and review of the literature.

Aslihan Pekmezci, Aydeniz Aydin Gumus, Ozge Polat Korkmaz

|Dec 16, 2024
Does de novo malignancy heighten the risk of rejection in kidney transplant recipients?

Erol Demir, Mevlut Tamer Dincer, Cebrail Karaca

|Sep 23, 2020
COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey

Umut Yılmaz, Aslıhan Pekmezci, Yalçın Gül

Pageof 1

Frequent Collaborators

2 joint publications

Sebnem Burhan

2 joint publications

Esra Hatipoglu

2 joint publications

Ebubekir Akpinar

2 joint publications

Aysel Unver Ozkahraman